You are here

Wilmar unit leads US$50m funding in pharma firm Accera


WILMAR Ventures, a wholly owned subsidiary of agribusiness group Wilmar International, led the first close of an investment round in brain health-focused pharmaceutical firm Accera. The first close comprised both equity investment and non-dilutive grants totalling US$50 million...

Market voices on: